ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
Navigating the Rare:
Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metastatic Melanoma with an Unknown Primary Origin Presenting with Postmenopausal Bleeding: A Case Report.Reports (MDPI) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastatic melanoma is the most life-threatening skin cancer due to its significant tendency to metastasize and its substantial resistance to therapeutic interventions. Melanomas spread aggressively, particularly to lymph nodes, the brain, and lungs, and can also involve the adrenal gland, liver, bones, and small intestine. Metastasis to the endometrium is exceedingly rare, with only a handful of documented cases. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is an excellent modality for detecting metastases. A meta-analysis showed that PET/CT has superior diagnostic performance, with 88% sensitivity and 94% specificity, compared to other contemporary imaging techniques. We present a 55-year-old postmenopausal female, diagnosed with primary cutaneous melanoma of the right foot and initially treated with temozolomide. After 2 years, she presented with vaginal bleeding. Restaging with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.